Quality Register for Geriatric Psychiatry

Depression Clinical Trial

— KVALAP  

Official title:

Quality Register for Geriatric Psychiatry in Viken Research Network for Geriatric Psychiatry

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01415310
• Other study ID #: KVALAP (QualGeP)
• Status: Recruiting
• Start date: April 2011
• Est. completion date: December 2030

Study information

• Verified date: July 2022
• Source: Norwegian Centre for Ageing and Health
• Contact: Lisbeth D Høgset, MSc
• Phone: 97582098
• Email: Lisebeth.Dyrendal.Hogset[@]sykehuset-innlandet.no
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

QualGeP (KVALAP) is a quality register in Viken Research network for Geriatric Psychiatry. The objectives of the register are to enhance our knowledge of old persons with severe psychiatric disorders, and to secure an optimal medical evaluation, treatment and care for these patients. The data in the register will be used for quality assurance and for research.

Aims:

• Quality assurance

• Further development of our diagnostic and screening tools

• Contributing to improving the treatment, with and without drugs

• Contributing to improving the dialogue and collaboration between primary healthcare and hospitals

Description:

Data collected:

• Demographic data

• Previous and present disorders and use of drugs

• Data from relatives regarding:

• the patient's cognition

• psychiatric health

• behaviour

• activities of daily living

• the stress and care burden of relatives

• Tests of cognitive functions

• Methods and duration for treatment

• Transfer to primary healthcare

• Possible readmissions

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 19000
• Est. completion date: December 2030
• Est. primary completion date: December 2030
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• Patients submitted to geriatric psychiatry units and their relatives who sign the consent form

Exclusion Criteria:

• Patients and relatives who refuse to sign the consent form

Related Conditions & MeSH terms

• Depression
• Geriatric Disorder

Locations

Country	Name	City	State
Norway	Old Age Psychiatry Unit, Diakonhjemmet Hospital	Oslo

Sponsors (4)

Lead Sponsor	Collaborator
Geir Selbaek	Diakonhjemmet Hospital, Oslo University Hospital, University Hospital, Akershus

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Depression and cognition	Scores on assessment scales (MADRS, Cornell scale, MMSE)	During admission